CCA's subseries, ASCO Direct™: A Patient Perspective, continues this week with MD Anderson's Dr. Christopher Logothetis. Tune in to learn about PARP Inhibitors and how the latest studies have become so consequential.
Comment down below any questions that you may have, topics that you would like to be further discussed, or feel free to share your own cancer-related story!
For a free consultation with CCA's world-class oncology team, please call 513-731-CARE or visit cincinnaticanceradvisors.org.
Please consider subscribing to our channel so you never miss out on any content! 👍
7 сен 2024
